New Sterilisation Partnership Underway with Industry Leader Andersen Caledonia
We’re pleased to announce that NGPOD is transitioning to a new sterilisation partner to further enhance the quality, reliability, and scalability of our supply chain. Validation of the NGPOD sensor sterilisation process is currently in progress at Andersen Caledonia.
Subject to approval by our Notified Body, we anticipate adopting Andersen Caledonia’s validated sterilisation cycle in Q1 2026.
This strategic move is an important milestone in de-risking production, ensuring regulatory compliance, and preparing NGPOD for the next stage of growth.
More from the newsfeed
September 7, 2025
NGPod Global at BAPEN 2025: Join us at ICC WalesSeptember 1, 2025
NGPOD to Showcase Next-Generation Digital pH Testing at HETT 2025June 25, 2025
NNNG and Welsh Stroke ConferenceFebruary 25, 2025
Nasogastric Safety: Past, Present and FutureJanuary 20, 2025
Supporting Future Healthcare ProfessionalsWHAT IS NGPOD?
NGPod: Stop "Never Events", improve patient recovery and reduce costs
The NGPod handheld devices overcomes many of the risks associated with existing Nasogastric placement confirmation methods.
- No aspiration required
- No interpretation required. Get a clear "Yes/No" answer
- Rapid result [c.15 seconds]
- Reduce delays to patients treatment, hydration and nutrition
- More cost-effective than testing with pH strips
